E-ISSN 2231-3206 | ISSN 2320-4672
 

Case Report

Online Publishing Date:
15 / 07 / 2017

 


Arsenic trioxide-induced QT interval prolongation: A case report

Devika Mohan, Raghuveer Prabhu, Remya Reghu.


Abstract
QT prolongation refers to the prolonged QT interval in electrocardiography (ECG) which can even lead to life-threatening events such as ventricular arrhythmias, torsades de pointes, etc., several drugs can cause QT prolongation which includes sotalol, quinidine, arsenic, disopyramide, procainamide, amiodarone, haloperidol, etc., Arsenic trioxide (ATO) is used as an effective treatment option in promyelocytic leukemia (PML). Acute myeloid leukemia (AML) is a cancer that affects the blood and bone marrow. Acute promyelocytic leukemia (APL) is the M3 subtype of AML that affects mainly the white blood cells. In APL, immature granulocytes accumulate abnormally to form promyelocytes. ATO helps in the apoptosis of these cancerous promyelocytic cells. In patients on arsenic therapy, ECGs must be monitored to ensure QT prolongation as it a major side effect of the drug. Here is the case of a 58-year-old female patient and was newly diagnosed with APL. She developed QT prolongation with arsenic therapy. Other confounding factors such as electrolytes and presence of other QT-prolonging drugs were also corrected.

Key words: Acute Promyelocytic Leukemia; Promyelocytes; QT Prolongation; Torsades De Pointes; Arsenic Trioxide


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Devika Mohan
Articles by Raghuveer Prabhu
Articles by Remya Reghu
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Devika Mohan, Raghuveer Prabhu, Remya Reghu. Arsenic trioxide-induced QT interval prolongation: A case report. Natl J Physiol Pharm Pharmacol. 2017; 7(8): 878-880. doi:10.5455/njppp.2017.7.0621330062017


Web Style

Devika Mohan, Raghuveer Prabhu, Remya Reghu. Arsenic trioxide-induced QT interval prolongation: A case report. https://www.njppp.com/?mno=270206 [Access: March 16, 2024]. doi:10.5455/njppp.2017.7.0621330062017


AMA (American Medical Association) Style

Devika Mohan, Raghuveer Prabhu, Remya Reghu. Arsenic trioxide-induced QT interval prolongation: A case report. Natl J Physiol Pharm Pharmacol. 2017; 7(8): 878-880. doi:10.5455/njppp.2017.7.0621330062017



Vancouver/ICMJE Style

Devika Mohan, Raghuveer Prabhu, Remya Reghu. Arsenic trioxide-induced QT interval prolongation: A case report. Natl J Physiol Pharm Pharmacol. (2017), [cited March 16, 2024]; 7(8): 878-880. doi:10.5455/njppp.2017.7.0621330062017



Harvard Style

Devika Mohan, Raghuveer Prabhu, Remya Reghu (2017) Arsenic trioxide-induced QT interval prolongation: A case report. Natl J Physiol Pharm Pharmacol, 7 (8), 878-880. doi:10.5455/njppp.2017.7.0621330062017



Turabian Style

Devika Mohan, Raghuveer Prabhu, Remya Reghu. 2017. Arsenic trioxide-induced QT interval prolongation: A case report. National Journal of Physiology, Pharmacy and Pharmacology, 7 (8), 878-880. doi:10.5455/njppp.2017.7.0621330062017



Chicago Style

Devika Mohan, Raghuveer Prabhu, Remya Reghu. "Arsenic trioxide-induced QT interval prolongation: A case report." National Journal of Physiology, Pharmacy and Pharmacology 7 (2017), 878-880. doi:10.5455/njppp.2017.7.0621330062017



MLA (The Modern Language Association) Style

Devika Mohan, Raghuveer Prabhu, Remya Reghu. "Arsenic trioxide-induced QT interval prolongation: A case report." National Journal of Physiology, Pharmacy and Pharmacology 7.8 (2017), 878-880. Print. doi:10.5455/njppp.2017.7.0621330062017



APA (American Psychological Association) Style

Devika Mohan, Raghuveer Prabhu, Remya Reghu (2017) Arsenic trioxide-induced QT interval prolongation: A case report. National Journal of Physiology, Pharmacy and Pharmacology, 7 (8), 878-880. doi:10.5455/njppp.2017.7.0621330062017